The prospective EU-US trade deal could be the world's biggest such treaty. The revolving door between public and private sectors is helping to grease the wheels of the TTIP corporate lobby. This phenomenon creates great potential for conflicts of interest, and demonstrates the synergies between business interests and the Commission, UK government, and others when it comes to trade negotiations.
An investigation led by research and campaign group Corporate Europe Observatory (CEO) and journalist Stéphane Horel exposes corporate lobby groups mobilising to stop the EU taking action on hormone (endocrine) disrupting chemicals (EDCs). The report sheds light on how corporations and their lobby groups have used numerous tactics from the corporate lobbying playbook: scaremongering, evidence-discrediting, and delaying tactics as well as the ongoing TTIP negotiations as a leverage.
The European Commission’s shocking leaked proposal for ”better regulation” would create pro-business bureaucratic mechanisms to prevent new laws - from regulating chemicals to preventing climate change - that could hurt the bottom line of corporations. Add TTIP and its 'regulatory co-operation' and US companies get in on the act too, with extra privileges.